Uroplakin II (BC21) Mouse
Uroplakin II (BC21) Mouse
| Application | IHC |
| Clone | BC21 |
| Conjugué | Unconjugated |
| Conseil | |
| Couleur | |
| Hôte | Mouse |
| Immunogène | |
| Isotype | IgG1 kappa |
| Localisation | |
| Pathologie | |
| Predicted reactivity | |
| Purification | |
| Réactivité | Human |
| Spécificité | |
| Taille | |
| Tissus controles | Normal Bladder, Urothelial Carcinoma of the Bladder |
Prêt à l'emploi
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 6 ml | MSG102 |
|
IVD/CE |
|
||
| 12 ml | MAD-000773QD-12 |
|
IVD/CE | RTU |
|
|
| 3 ml | MAD-000773QD-3 |
|
IVD/CE | RTU |
|
|
| 7 ml | MAD-000773QD-7 |
|
IVD/CE | RTU |
|
Concentré
| Conditionnement | Reference | Supplier | Certification | Dilution | TDS | Quantity |
|---|---|---|---|---|---|---|
| 0,5 ml | MSK102-05 |
|
IVD/CE | 1/50 - 1/100 |
|
|
| 1 ml | MAD-000773Q |
|
IVD/CE |
|